WarrenTaylorMD

Psychiatry • Nashville, TN

Geriatric Psychiatry

James G. Blakemore Professor of Psychiatry, Department of Psychiatry and Behavioral Sciences, Vanderbilt University Medical Center

Join to view full profile

Dr. Taylor is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Taylor's full profile

Already have an account?

Office
3601 The Vanderbilt Clinic
Nashville, TN 37232
Phone+1 615-936-2000

Summary

Dr. Warren Taylor is a geriatrician in Nashville, TN and is affiliated with Vanderbilt University Medical Center. He received his medical degree from University of South Florida Morsani College of Medicine and has been in practice 21 years. He is experienced in geriatric psychiatry, mood disorders, and psychiatry.

Education & Training

Duke University HospitalFellowship, Geriatric Psychiatry, 2000 - 2001
Duke University HospitalResidency, Psychiatry, 1996 - 2000
University of South Florida College of MedicineClass of 1996

Certifications & Licensure

TN State Medical License 2012 - 2026
AL State Medical License 2020 - 2020
NC State Medical License 1997 - 2014
American Board of Psychiatry and Neurology Psychiatry
American Board of Psychiatry and Neurology Geriatric Psychiatry

Clinical Trials

Late-life Depression and Cerebral Perfusion Start of enrollment: 2012 Dec 01
Withdrawn
Not Applicable
Effects of Cerebral Hypoperfusion and Its Reversal on Late-Life Depression Start of enrollment: 2013 May 01
Terminated
Phase 4
Frontal Hypoperfusion Effects on Antidepressant Outcomes in Late-Life Depression Start of enrollment: 2013 Jul 01
Completed
Phase 4
Dopaminergic Dysfunction in Late-Life Depression Start of enrollment: 2021 Feb 15
Recruiting
Phase 2
Depressed Mood Improvement Through Nicotine Dosing-3 (Depressed MIND3) Extension Start of enrollment: 2023 Apr 15
Recruiting
Phase 2
Depressed Mood Improvement Through Nicotine Dosing 2 Start of enrollment: 2020 Dec 15
Completed
Phase 2
Depressed Mood Improvement Through Nicotine Dosing (Depressed MIND Study) Start of enrollment: 2016 Oct 01
Completed
Phase 4
Connectivity Affecting the Antidepressant REsponse Study Start of enrollment: 2015 Apr 01
Completed
Phase 4
Join now to see all

Publications & Presentations

PubMed

3 citations
The relationship of mental health symptoms to chemotherapy toxicity risk in older adults with cancer: Results from the geriatric assessment-driven intervention study.
Reena V Jayani, Anahid Hamparsumian, Canlan Sun, Daneng Li, Leana Cabrera Chien
Cancer. 2024-11-15
Selective serotonin/serotonin-norepinephrine reuptake inhibitor serum concentrations' association with delirium duration.
James O Jordano, Eduard E Vasilevskis, Sandra F Simmons, Warren D Taylor, Andrew A Monte
Journal of the American Geriatrics Society. 2024-11-01
1 citations
Effects of open-label transdermal nicotine antidepressant augmentation on affective symptoms and executive function in late-life depression.
Patricia Andrews, Jennifer N Vega, Sarah M Szymkowicz, Paul Newhouse, Rachel Tyndale
Journal of Affective Disorders. 2024-10-01

Press Mentions

COVID-19 Pandemic Has Compounded Physician BurnoutJuly 27th, 2021
Test May Offer Clues About Elderly Patients Likely to Benefit from AripiprazoleMarch 10th, 2016
Depression Study Seeks to Predict Treatment ResponseSeptember 10th, 2015

Grant Support

1/3: Recurrence Markers, Cognitive Burden, and Neurobiological Homeostasis in Late-Life Depression (The REMBRANDT Study)National Institute of Mental HealthPresent